Holen Sie sich die Stockscreener-App
35.55
5.30%
1.79
Vorhandelsmarkt:
35.35
-0.20
-0.56%
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush - MarketBeat
Why Scholar Rock Shares Are Soaring Today - The Globe and Mail
Scholar Rock (NASDAQ:SRRK) Shares Gap UpWhat's Next? - MarketBeat
Transcript : Scholar Rock Holding CorporationSpecial Call - MarketScreener
Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results - Yahoo Finance
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study - Benzinga
Scholar Rock stock soars after drug shows promise in preserving lean mass during weight loss - Investing.com Australia
Trading Day Triumph: Scholar Rock Holding Corp (SRRK) Ends at 31.15, a -3.05 Surge/Plunge - DWinneX
Scholar Rock's drug helps Zepbound patients retain more muscle in trial - marketscreener.com
Scholar Rock (SRRK) Surges 14% Following EMBRAZE Trial Results | SRRK Stock News - GuruFocus
Scholar Rock (SRRK) Surges After Promising Weight Loss Trial - GuruFocus
Scholar Rock Reports Positive Results From Phase 2 EMBRAZE Study - Nasdaq
Scholar Rock stock gains on weight loss data (SRRK:NASDAQ) - Seeking Alpha
Scholar Rock (SRRK) Reveals Phase 2 Trial Success of Apitegromab with Tirzepatide | SRRK Stock News - GuruFocus
Scholar Rock's drug helps patients on Zepbound preserve muscle in trial - MarketScreener
Scholar Rock’s apitegromab preserves lean mass during weight loss - Investing.com
Scholar Rock's drug helps preserve lean mass in mid-stage trial - marketscreener.com
Scholar Rock's Breakthrough Drug Shows 55% Better Muscle Preservation in Weight Loss Study - Stock Titan
Notable Two Hundred Day Moving Average CrossSRRK - Nasdaq
Scholar Rock Holding Corp Executives Sell Shares to Cover Tax Obligations - TradingView
GAMMA Investing LLC Buys 30,140 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) - MarketBeat
GAMMA Investing LLC Has $962,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Rhumbline Advisers Purchases 7,491 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased By Stocktwits - Investing.com India
Scholar Rock at Goldman Sachs Conference: Strategic Focus on SMA By Investing.com - Investing.com Nigeria
Transcript : Scholar Rock Holding Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09 - MarketScreener
Truist Financial Sticks to Its Buy Rating for Nurix Therapeutics (NRIX) - The Globe and Mail
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Increased by California State Teachers Retirement System - MarketBeat
Scholar Rock (NASDAQ:SRRK) Trading Up 5.9%Here's What Happened - MarketBeat
Lifesci Capital Weighs in on Scholar Rock Q2 Earnings - MarketBeat
Scholar Rock (NASDAQ:SRRK) Upgraded at Lifesci Capital - MarketBeat
Exploring Three High Growth Tech Stocks In The US Market - Yahoo Finance
Mackenzie Financial Corp Invests $212,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Analysts Set Expectations for Scholar Rock Q2 Earnings - Defense World
Scholar Rock Spotlights Revolutionary SMA Treatment at Goldman Sachs Healthcare Conference 2025 - Stock Titan
Squarepoint Ops LLC Takes $873,000 Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) Stock Rating Upgraded by Lifesci Capital - Defense World
Scholar Rock at Jefferies: Leadership Changes and Drug Launch Plans By Investing.com - Investing.com South Africa
Scholar Rock at Jefferies: Leadership Changes and Drug Launch Plans - Investing.com
Ameriprise Financial Inc. Has $813,000 Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Insider Akshay Vaishnaw Sells 6,750 Shares - MarketBeat
Scholar Rock (NASDAQ:SRRK) Trading Down 6.2%Time to Sell? - MarketBeat
Scholar Rock appoints new Chief Brand Officer By Investing.com - Investing.com South Africa
Wellington Management Group LLP Buys 1,525,845 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Director Jeffrey S. Flier Sells 6,075 Shares - MarketBeat
Insider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Director Sells 5,400 Shares of Stock - MarketBeat
Regeneron's weight-loss drug helps patients on Wegovy preserve muscle - marketscreener.com
Scholar Rock appoints new Chief Brand Officer - Investing.com Australia
Scholar Rock (SRRK) Appoints Rebecca McLeod as Chief Brand Officer | SRRK Stock News - GuruFocus
Scholar Rock Taps Blockbuster VYVGART Launch Executive to Lead Crucial SMA Drug Commercialization - Stock Titan
Polar Asset Management Partners Inc. Sells 28,000 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):